ROIV

Roivant Sciences Ltd (ROIV)

US
$ 11.010.09%

Price Chart

Key Statistics

Market Cap
$ 8.06B
P/E Ratio
0.00
Revenue (TTM)
$ 122.59M
Volume
7.95M
52W High
$ 13.05
52W Low
$ 8.73
Dividend Yield
0.00%
Beta
1.25

Technicals

50-Day MA
10.4224
200-Day MA
11.2542
52 Week High
13.055
52 Week Low
8.73

About ROIV

Roivant Sciences Ltd., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas.

Employees
908
Headquarters
London, United Kingdom
CEO
Mr. Matthew Gline

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
LGMK
LogicMark Inc. Comm...
$ 0.03
140.31
WLDS
Wearable Devices Lt...
$ 1.73
44.17
DMN
Damon Inc. Common S...
$ 0.01
32.89
LEG
Leggett & Platt Inc...
$ 9.58
31.96
BON
Bon Natural Life Li...
$ 0.08
23.08

Top Losers

Symbol/Name
LTP
% Chg
SMCI
Super Micro Compute...
$ 30.60
-17.90
UAVS
AgEagle Aerial Syst...
$ 0.96
-15.04
MLGO
MicroAlgo Inc. Ordi...
$ 6.08
-14.49
HTZ
Hertz Global Holdin...
$ 7.29
-14.34
FSLR
First Solar Inc. Co...
$ 122.59
-12.25